CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Clearpoint Neuro Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Clearpoint Neuro Inc
120 S. SIERRA AVENUE, SUITE 100
Phone: (949) 900-6833p:949 900-6833 SOLANA BEACH, CA  92075  United States Ticker: MRICMRIC
Business Summary
ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3845 Electromedical and electrotherapeutic apparatus
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board R. JohnFletcher 78 2/4/2021 5/1/2017
President, Chief Executive Officer, Director Joseph M.Burnett 47 11/7/2017 11/7/2017
Chief Financial Officer DaniloD' Alessandro 39 1/1/2024 9/29/2020
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
CLEARPOINT NEURO ITALY S.R.L. CSO VERCELLI, 40 MILANO Italy
CLEARPOINT NEURO UK LTD OLYMPUS AVENUE LEAMINGTON SPA WARWICKSHIRE United Kingdom

Business Names
Business Name
ClearPoint Neuro (Canada) Inc.
ClearPoint Neuro Germany GmbH.
ClearPoint Neuro Italy, S.r.l.
5 additional Business Names available in full report.

General Information
Number of Employees: 107 (As of 3/5/2024)
Outstanding Shares: 27,584,699 (As of 10/31/2024)
Shareholders: 230
Stock Exchange: NASD
Federal Tax Id: 582394628
Fax Number: (949) 900-6834


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024